INDIA based Bharat Biotech International, has launched BioHib, the first Indigenously developed and manufactured Haemophilus influenza type b (Hib) vaccine in India. It also launched its tetravalent combination vaccine, Comvac4-HB containing Diphtheria, Pertussis, Tetanus and Hepatitis B in one vaccine. These two new vaccines BioHib and Comvac4-HB, enable the deployment of a combination pentavalent vaccine in a single injection. BioHib is a conjugate vaccine that has proven its safety and efficacy in multi-centric clinical trials. BioHib will be a safe and affordable vaccine that offers complete protection against Hib infections. It is a safe and efficacious vaccine developed with conjugation and manufacturing technologies developed at Bharat Biotech.